Table 3:
INa§ | Late-INa§ | ICa,L‡ | IK1§ | IKv1.5∥ | ITo§ | |
---|---|---|---|---|---|---|
pA/pF | pA/pF | pA/pF | pA/pF | pA/pF | pA/pF | |
Control | −72.3±4.9 | 0.27±0.01 | −47.0±5.4 | −76.0±9.5 | 4.3±0.7 | 42.5±2.9 |
ANP oligo | −47.1±3.1* | 0.22±0.01* | −31.7±3.8* | −45.9±5.9* | 7.1±0.7* | 47.1±3.1* |
Control | −59.0±4.7 | 0.24±0.004 | −28.9±3.9 | −96.4±15 | 12.3±1.5 | 46.5±3.2 |
mutANP | −42.7±3.2* | 0.20±0.002† | −18.1±2.5† | −58.2±9.0* | 13.3±1.7* | 54.3±3.5* |
Control | −59.6±6.0 | 0.23±0.004 | −59.3±7.5 | −88.4±7.8 | 15.3±2.5 | 48.5±3.2 |
mutANP oligo | −39.2±4.4* | 0.17±0.004† | −34.5±3.0† | −54.8±5.8* | 18.9±3.1* | 70.1±4.6* |
Control | −50.5±3.0 | 0.32±0.004 | −38.0±2.2 | −101.7±6.6 | 17.3±2.6 | 43.8±1.6 |
BNP oligomer | −36.5±2.6* | 0.22±0.003† | −46.7±3.3* | −80.5±6.8* | 22.2±3.5* | 51.5±1.9* |
oligo represents oligomer
P<0.05
P<0.01
mouse atrial cells (n=3 mice for each group; n=7-15)
HL-1 cells (n=7-16)
Ltk− cells (n=7-13)